Search Results - Honma, Rio

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Role of targeted therapy in metastatic colorectal cancer

    Role of targeted therapy in metastatic colorectal cancer by Ohhara, Yoshihito, Fukuda, Naoki, Takeuchi, Satoshi, Honma, Rio, Shimizu, Yasushi, Kinoshita, Ichiro, Dosaka-Akita, Hirotoshi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case report

    Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case report by Iijima, Kazutaka, Takayama, Toshizo, Shindo, Satoko, Moku, Rika, Sawai, Koya, Honma, Rio, Hyakushima, Naoki, Akino, Tomoshige, Oyamada, Yumiko, Tsuji, Yasushi

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Late Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor

    Late Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor by Takeuchi, Satoshi, Goda, Tomohiro, Taguchi, Jun, Douhata, Yuichi, Honma, Rio, Ariga, Shin, Ohhara, Yoshihito, Shimizu, Yasushi, Kinoshita, Ichiro, Fukuda, Izumi, Nagashima, Yoji, Akita, Hirotoshi

    Published in Internal Medicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study

    Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospec... by Takeuchi, Satoshi, Hirata, Kenji, Magota, Keiichi, Watanabe, Shiro, Moku, Rika, Shiiya, Akihiko, Taguchi, Jun, Ariga, Shin, Goda, Tomohiro, Ohhara, Yoshihito, Noguchi, Takurou, Shimizu, Yasushi, Kinoshita, Ichiro, Honma, Rio, Tsuji, Yasushi, Homma, Akihiro, Dosaka-Akita, Hirotoshi

    Published in EJNMMI research
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck

    Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck by Taguchi, Jun, Shimizu, Yasushi, Ariga, Shin, Goda, Tomohiro, Ohhara, Yoshihito, Honma, Rio, Noguchi, Takuro, Takeuchi, Satoshi, Kinoshita, Ichiro, Amano, Toraji, Mizumachi, Takatsugu, Kano, Satoshi, Takahara, Miki, Abe, Takahisa, Homma, Akihiro, Dosaka-Akita, Hirotoshi

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity

    Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity by Saito, Yoshitaka, Kobayashi, Masaki, Yamada, Takehiro, Kasashi, Kumiko, Honma, Rio, Takeuchi, Satoshi, Shimizu, Yasushi, Kinoshita, Ichiro, Dosaka-Akita, Hirotoshi, Iseki, Ken

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy

    A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy by Takeuchi, Satoshi, Honma, Rio, Taguchi, Jun, Amano, Toraji, Shimizu, Yasushi, Kinoshita, Ichiro, Kubota, Kanako, Matsuno, Yoshihiro, Dosaka-Akita, Hirotoshi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Early prediction of treatment outcome for lenvatinib using 18 F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study

    Early prediction of treatment outcome for lenvatinib using 18 F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospe... by Takeuchi, Satoshi, Hirata, Kenji, Magota, Keiichi, Watanabe, Shiro, Moku, Rika, Shiiya, Akihiko, Taguchi, Jun, Ariga, Shin, Goda, Tomohiro, Ohhara, Yoshihito, Noguchi, Takurou, Shimizu, Yasushi, Kinoshita, Ichiro, Honma, Rio, Tsuji, Yasushi, Homma, Akihiro, Dosaka-Akita, Hirotoshi

    Published in EJNMMI research
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Abstract 2625: Clinicopathological features of programmed cell death ligand 1 (PD-L1) expression in resected non-small cell lung cancers

    Abstract 2625: Clinicopathological features of programmed cell death ligand 1 (PD-L1) expression in resected non-small cell lung cancers by Ohhara, Yoshihito, Kinoshita, Ichiro, Tomaru, Utano, Hatanaka, Kanako C., Hatanaka, Yutaka, Honma, Rio, Takeuchi, Satoshi, Shimizu, Yasushi, Kaga, Kichizo, Matsuno, Yoshihiro, Dosaka-Akita, Hirotoshi

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Abstract 3164: Decreased expression of GDP-mannose-4,6-dehydratase (GMD) and GDP-fucose transporter is associated with squamous histology in non-small cell lung cancers (NSCLCs)

    Abstract 3164: Decreased expression of GDP-mannose-4,6-dehydratase (GMD) and GDP-fucose transporter is associated with squamous histology in non-small cell lung cancers (NSCLCs) by Honma, Rio, Kinoshita, Ichiro, Miyoshi, Eiji, Matsuno, Yoshihiro, Shimizu, Yasushi, Kaga, Kichizo, Taniguchi, Naoyuki, Dosaka-Akita, Hirotoshi

    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy

    A Case of High-Grade Neuroendocrine Carcinoma That Improved with Bevacizumab plus Modified FOLFOX6 as the Fourth-Line Chemotherapy by Takeuchi, Satoshi, Honma, Rio, Taguchi, Jun, Amano, Toraji, Shimizu, Yasushi, Kinoshita, Ichiro, Kubota, Kanako, Matsuno, Yoshihiro, Dosaka-Akita, Hirotoshi

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: